Drug Interactions between Diacomit and ledipasvir / sofosbuvir
This report displays the potential drug interactions for the following 2 drugs:
- Diacomit (stiripentol)
- ledipasvir/sofosbuvir
Interactions between your drugs
No interactions were found between Diacomit and ledipasvir / sofosbuvir. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Diacomit
A total of 615 drugs are known to interact with Diacomit.
- Diacomit is in the drug class gamma-aminobutyric acid reuptake inhibitors.
- Diacomit is used to treat Dravet Syndrome.
ledipasvir / sofosbuvir
A total of 178 drugs are known to interact with ledipasvir / sofosbuvir.
- Ledipasvir / sofosbuvir is in the drug class antiviral combinations.
- Ledipasvir / sofosbuvir is used to treat Hepatitis C.
Drug and food interactions
stiripentol food
Applies to: Diacomit (stiripentol)
Stiripentol should be taken during a meal to help with its absorption; however, it should not be taken with milk, dairy products (e.G., yogurt, soft cream cheese), fruit juice, or carbonated (fizzy) beverages. Also avoid or limit the use of alcohol because it can increase side effects of stiripentol such as dizziness and drowsiness. Patients should not engage in activities requiring mental alertness such as driving or operating hazardous machinery until they know how the medication affects them. Food and beverages that may contain caffeine or theophylline such as colas, chocolate, coffee, tea, or energy drinks should also be avoided, since stiripentol may affect the clearance of these substances from the body. Some medications may also contain caffeine, so check product labels to verify the ingredients before taking, or ask a pharmacist or other healthcare provider for assistance. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.